Cita APA

Rojo, F., Torrecillas, L., Ruiz-Borrego, M., Bines, J., Torres, R., de la Haba Rodríguez, J. R., . . . S. Ray, P. (2025). FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial.

Citación estilo Chicago

Rojo, Federico|||0000-0001-9989-0290, et al. FOXC1 Expression Predicts Capecitabine Efficacy in Patients With Triple-Negative Breast Cancer From the GEICAM_CIBOMA Trial. 2025.

Cita MLA

Rojo, Federico|||0000-0001-9989-0290, et al. FOXC1 Expression Predicts Capecitabine Efficacy in Patients With Triple-Negative Breast Cancer From the GEICAM_CIBOMA Trial. 2025.